HomeStyles-Adults of Chinese Heritage
NCT06136793
Behavior, Behavior, Animal
New Brunswick, New Jersey, United States
View Trial DetailsNCT Number: NCT07762729
This prospective observational birth cohort study aims to characterize the longitudinal development of the gut microbiome during early childhood and to investigate its associations with prenatal, perinatal, and postnatal exposures and child growth and health outcomes.
Approximately 1000 pregnant women will be enrolled, and their children will be followed from birth to 36 months of age. Information on parental demographic and lifestyle characteristics, maternal pre-pregnancy and pregnancy-related factors, prenatal examinations, delivery characteristics, infant feeding, medication use, illnesses, and household and environmental factors will be collected through questionnaires and medical records.
Child anthropometric measurements and fecal samples will be collected at birth and at 1, 3, 6, 9, 12, 18, 24, and 36 months of age. The fecal microbiome will be characterized using shotgun metagenomic sequencing.Umbilical cord blood will be collected at delivery from all participants, subject to informed consent and hospital procedures. At 36 months of age, residual venous blood remaining after routine health examinations and clinically indicated laboratory testing will be retained for research from all participating children.
The study will evaluate the developmental trajectories of the early-life gut microbiome and identify maternal, paternal, perinatal, feeding-related, medication-related, and environmental factors associated with microbiome development and subsequent child growth and health.
Interested in participating?
Request Info0 month–36 month
All sexes
Observational
Yiyang Maternal and Child Health Hospital, Yiyang, Hunan, China
Early childhood is a critical period for the establishment and maturation of the gut microbiome. Microbiome development during this period may be influenced by maternal health, pregnancy-related factors, mode of delivery, gestational age, infant feeding, medication exposure, infections, household conditions, and other early-life exposures.
This prospective, longitudinal, observational birth cohort study will recruit approximately 1000 pregnant women and follow their children from birth to 36 months of age. No intervention will be assigned by the investigators, and participants will receive routine maternal and child healthcare according to local clinical practice.
Information on parental demographic, health, anthropometric, and lifestyle characteristics; maternal pre-pregnancy and pregnancy-related factors; prenatal examinations; delivery and neonatal characteristics; infant feeding and diet; medication use; illnesses; vaccination; hospitalization; and household and environmental factors will be collected through questionnaires and medical records. Child growth will be assessed using standardized anthropometric measurements.
Fecal samples will be collected at birth and at 1, 3, 6, 9, 12, 18, 24, and 36 months of age using standardized procedures. Shotgun metagenomic sequencing will be used to characterize the taxonomic composition and functional potential of the gut microbiome and to evaluate its longitudinal developmental patterns.
Umbilical cord blood collection will be planned at delivery for all participants, subject to informed consent, collection feasibility, and institutional procedures. At 36 months of age, residual venous blood remaining after routine health examinations and clinically indicated laboratory testing may be retained for research. All biological specimens will be processed and stored according to standardized operating procedures.
Longitudinal statistical methods will be used to evaluate age-related microbiome changes and their associations with early-life exposures and child outcomes. Analyses will account for repeated measurements, relevant potential confounders, missing data, loss to follow-up, multiple comparisons, and the compositional nature of microbiome data. Exploratory analyses may assess whether gut microbiome characteristics mediate or modify associations between early-life exposures and subsequent child outcomes.
As this is an observational study, identified associations will not by themselves establish causal relationships. The study is expected to provide evidence on gut microbiome development during early childhood and to inform future mechanistic and preventive research.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At birth and at 1, 3, 6, 9, 12, 18, 24, and 36 months of age
Gut microbial taxonomic composition will be characterized from stool samples using shotgun metagenomic sequencing and summarized as the relative abundance of microbial taxa.
Time frame: At birth and at 1, 3, 6, 9, 12, 18, 24, and 36 months of age
Infant body weight will be measured in kilograms at postnatal follow-up visits and summarized as longitudinal change in body weight over time.
Time frame: At birth and at 1, 3, 6, 9, 12, 18, 24, and 36 months of age
Infant body length will be measured in centimeters at postnatal follow-up visits and summarized as longitudinal change in body length over time.
Time frame: At 1, 3, 6, 9, 12, 18, 24, 30, and 36 months after birth
Infant head circumference will be measured in centimeters at postnatal follow-up visits and summarized as longitudinal change in head circumference over time.
Time frame: At 1, 3, 6, 9, 12, 18, 24, 30, and 36 months after birth
Infant feeding pattern will be assessed using follow-up questionnaires, including exclusive breastfeeding, predominant breastfeeding, mixed feeding, formula feeding, and complementary food intake.
Children's Hospital of Fudan University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06136793
Behavior, Behavior, Animal
New Brunswick, New Jersey, United States
View Trial DetailsNCT06645223
Diabetes Mellitus, Endocrine System Diseases
Beijing, China
View Trial DetailsNCT06157346
Children, Only, Gut Microbiota
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT07214428
Gut Microbiota, Psychological Distress
New Brunswick, New Jersey, United States
View Trial Details